Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Zuckerman Supports Idea Of National Percutaneous Valve Registry

This article was originally published in The Gray Sheet

Executive Summary

The development of percutaneous heart valves would benefit from a centralized postmarket registry based on standardized adverse event definitions, according to participants in a recent FDA workshop

You may also be interested in...



Industry Presents Wish List For DES Guidance At CRT Conference

FDA's forthcoming guidance on drug-eluting stents should provide specific requirements for preclinical, clinical and postmarket studies to help manufacturers get safe products to market quickly, according to stakeholders

INTERMACS Registry Will Light The Way To Earlier VAD Therapy – Editorial

The ongoing INTERMACS registry holds the key to expanding the usefulness of ventricular assist devices from just extending life to improving the quality of life, according to Lynne Warner Stevenson, cardiac surgeon at Brigham and Women's Hospital, Boston

Drug-Eluting Stent Panelists Could Not Agree On Definition Of Thrombosis

FDA advisory panel members examining the risks of thrombosis in on- and off-label use of drug-eluting stents earlier this month could not reach a consensus on which definition of thrombosis to use

Related Content

UsernamePublicRestriction

Register

MT025807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel